|
|
 | | | |
- close
- close
- close
- close
GSK » Topics » GSK also markets Priorix , a measles, mumps and rubella vaccine, Typherix , a vaccine for protection against typhoid fever, and Varilrix , a vaccine against varicella or chicken pox. Priorix-Tetra , GSKs new combination vaccine to prevent measles, mumps,This excerpt taken from the GSK 20-F filed Feb 29, 2008. GSK also markets Priorix,
a measles, mumps and rubella vaccine, Typherix,
a vaccine for protection against typhoid fever, and Varilrix,
a vaccine against varicella or chicken pox. Priorix-Tetra,
GSK’s new combination vaccine to prevent measles, mumps, rubella and
varicella (MMRV) was first launched in Germany in August 2006. In addition,
the Group markets a range of vaccines to prevent meningitis under the umbrella
name Mencevax. GSK’s new Hib-MenC vaccine, Menitorix is
now available in the UK. GSK’s meningitis vaccine portfolio will be
complemented by new meningitis conjugate vaccines in the near future.
As part of its paediatric franchise, GSK continued to roll out the launch of its vaccine against rotavirus induced gastroenteritis, Rotarix, which is now launched in 90 countries worldwide. Rotavirus vaccination has been included in the national vaccination calendar of five Latin American countries where Rotarix will be available free at public health clinics, as part of governmental paediatric immunisation programmes. |
| |||||||
